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Background Growth curve analysis is a statistical issue in life course epidemi-
ology. Height in puberty involves a growth spurt, the timing and
intensity of which varies between individuals. Such data can be
summarized with individual Preece–Baines (PB) curves, and their
five parameters then related to earlier exposures or later outcomes.
But it involves fitting many curves.
Methods We present an alternative SuperImposition by Translation And
Rotation (SITAR) model, a shape invariant model with a single
fitted curve. Curves for individuals are matched to the mean curve
by shifting their curve up–down (representing differences in mean
size) and left–right (for differences in growth tempo), and the age
scale is also shrunk or stretched to indicate how fast time passes in
the individual (i.e. velocity). These three parameters per individual
are estimated as random effects while fitting the curve. The outcome
is a mean curve plus triplets of parameters per individual (size,
tempo and velocity) that summarize the individual growth patterns.
The data are heights for Christ’s Hospital School (CHS) boys aged
9–19 years (N¼3245, n¼129508), and girls with Turner syndrome
(TS) aged 9–18 years from the UK Turner Study (N¼105, n¼1321).
Results The SITAR model explained 99% of the variance in both datasets
[residual standard deviation (RSD) 6–7mm], matching the fit of
individually-fitted PB curves. In CHS, growth tempo was associated
with insulin-like growth factor-1 measured 50 years later (P¼0.01,
N¼1009). For the girls with TS randomized to receive oxandrolone
from 9 years, velocity was substantially increased compared with
placebo (P¼10
 8).
Conclusions The SITAR growth curve model is a useful epidemiological instru-
ment for the analysis of height in puberty.
Keywords Height, puberty, Turner syndrome, growth curve, random effects
Introduction
A child’s growth curve contains considerable informa-
tion about their genetic make-up and environmental
exposure.
1 It can be useful to characterize the nature
of the curve and relate it both to previous or current
exposures and putative later outcomes.
2 Thus, the
characterization of the growth curve is an important
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1558first stage in the life course study of early growth and
later outcome.
By its nature the growth curve consists of a series of
highly correlated measurements, and it is important
to reduce the dimensionality of the data to simplify
comparisons between individual children. The trad-
itional approach is to identify a suitable parametric
model for the given measurement and age range, for
example the Jenss–Bayley curve
3 for weight in early
life or the Preece–Baines (PB) curve
4 for height in
puberty. The growth curve is then entirely character-
ized by the fitted parameters of the model, which can
be used instead of the raw data to test for associations
with exposure and/or outcome.
This article focuses on height in puberty, where the
PB curve with its five estimated parameters fits indi-
vidual growth curves extremely well, with a residual
standard deviation (SD) of 6–7mm.
4,5 However, as a
summary of the underlying curve its five parameters
are relatively high-dimensional for many purposes.
The ideal approach would be to fit a form of curve
to all subjects simultaneously, and to estimate the
subject-specific parameter values as subject random
effects. Such an approach could in principle be
applied to the PB curve. However, Beath
6 introduced
a considerable simplification to the analysis of growth
curves by describing a shape invariant model of infant
weight. This consists of a single growth curve, which
can be applied to all subjects by applying just three
subject-specific translations and rotations of the curve
to fit the individual subject growth curves.
The aim here is to fit the model described by Beath
6
and show how effectively it summarizes height
growth around the time of puberty. The second aim
is to show how the estimated subject-specific param-
eters can be related to earlier exposures and later
outcomes.
Methods
Data sets
Two data sets are used as examples, both of height in
puberty. The first, the Christ’s Hospital School (CHS)
cohort, consisted of a sample of 3245 boys, who at-
tended the school at some stage between 1939 and
1968 and were measured twice a term between the
ages of 9 and 19 years [median 42 measurements per
boy, inter-quartile (IQR) range 35–47, range 1–63], a
total of 129508 heights. These were linked to follow-
up data on 1520 adults, some 50 years later, when
inter alia height and insulin-like growth factor 1
(IGF-1) levels were measured. The cohort has been
described in detail previously,
7–9 and an inverse asso-
ciation between age at peak height velocity (APHV)
and later IGF-1 has been reported.
9 This was based on
estimates of APHV for each child derived from spline
curves fitted to each child’s data.
The second data set came from a randomized clin-
ical trial of oxandrolone to increase final height in
girls with Turner syndrome (TS). This is a chromo-
somal disorder where the second X chromosome is
missing or malformed, leading to short stature and
primary ovarian failure. A total of 106 girls with TS
already on a standard dose of growth hormone were
randomized to receive either oxandrolone or placebo
from the age of 9 years (or the age at recruitment if
later) until final height was reached. One girl dropped
out immediately and 13 more later on, whereas
92 girls remained in the study and 82 had reached
final height before the time of analysis. A total of
1321 heights were included in the analysis (median
12 per child, IQR 9–17, range 1–23). The trial, which
also included a second randomization to early or late
oestrogen for induction of puberty, is reported in
detail elsewhere (EJ Gault et al., submitted for
publication).
The SITAR model
The method used to summarize the individual growth
curves followed that of Beath,
6 and was also an exten-
sion of the model developed independently by the first
author and colleagues.
7 This is a shape invariant
model
10,11 that involves fitting the following random
effects model to the set of height growth curves:
yit ¼ i þ h
t   i
expð iÞ

ð1Þ
where yit is height for subject i at age t, h(t) is a nat-
ural cubic spline curve of height vs age, and i, i and
i are subject-specific random effects. The aim is to
choose the values of i, i and i to make the indi-
vidual growth curves as similar as possible, i.e. the
mean spline curve h(t). Their interpretations are as
follows:
  i is a random height intercept that adjusts for
differences in mean height—here it is termed size.
Geometrically it can be thought of as a subject-
specific shift up or down or translation in the
spline curve, with i smaller for shorter children.
  i is a random age intercept to adjust for differ-
ences in the timing of the pubertal growth spurt
in individuals i.e. the APHV, and it is here called
tempo following Tanner’s usage. Geometrically it
corresponds to a subject-specific left–right shift or
translation in the spline curve, with i negative for
early puberty and positive for late.
  i is a random age scaling that adjusts for the dur-
ation of the growth spurt in individuals. Its param-
eterization as exp(–i) ensures that both positive
and negative values are permissible, with zero cor-
responding to average velocity, and the minus sign
means that it measures velocity rather than its in-
verse. (This minus sign is the reverse of Beath’s
notation.) Geometrically it corresponds to a shrink-
ing or stretching of the age scale. Thus for a child
SITAR—A USEFUL INSTRUMENT FOR GROWTH CURVE ANALYSIS 1559with a relatively short spurt and a steep growth
curve, i is positive to stretch the age scale and
reduce the slope (i.e. peak velocity). Conversely, if
i is negative the age scale is shrunk and the curve
slope increased. For this reason the parameter is
termed velocity. Note that its effect is to make
growth curves steeper or shallower, so it effectively
rotates each curve (this terminology makes clear its
similarity to a random slope effect, though strictly
it is a scale change rather than a rotation).
Figure 1 illustrates the meanings of the three par-
ameters geometrically, i.e. the three ways in which
the mean growth curve (black solid line) can be
transformed to match an individual’s growth curve.
Size is an up–down shift on the height axis (red
dashed lines) and tempo is a right-left shift on the
age axis (blue long dashed lines), while velocity is a
shrinking–stretching of the age axis (green
dot-dashed lines). The pairs of lines represent 95%
of the population variation (i.e.  2 SD). The principle
is that by suitable choice of these subject-specific par-
ameters, smoothed estimates of each individual
growth curve can be obtained by transformation of
the mean curve. This leads to a particularly simple
way of assessing goodness of fit. If the model fits
well, each individual curve can be back-transformed
using the subject’s triplet of estimated parameters,
and all the curves should then sit on top of the
mean curve. Expressed in words, the model allows
individual curves to be super-imposed by translation
and rotation, leading to the happy acronym SITAR
(SuperImposition by Translation And Rotation). This
is the SITAR model for growth curve analysis.
The model was fitted using the nlme function
12
in R,
13 with the age term centred to mean zero, the
three parameters fitted as random effects and size and
velocity also as fixed effects, and h(t) a natural cubic
spline curve with 6 degrees of freedom (df) fitted as
fixed effects. Height and age were fitted both untrans-
formed and log transformed, to identify the optimal
underlying scales.
Growth related to exposure and outcome
In the CHS cohort, the relationships between the
SITAR parameters and the outcome measures of
height and IGF-1 at follow-up 50 years later were
investigated using correlation and regression.
The analysis of the TS clinical trial data involved
comparing the SITAR parameters in individuals in
the two trial arms. This was done in three ways.
(i) Comparing the mean values of each growth
parameter in the two arms using t-tests.
(ii) Extending the SITAR model to include fixed
effects for each parameter by trial arm.
(iii) Fitting the SITAR model to the data for each
trial arm separately, to demonstrate differences
in the two mean curves.
The first two approaches test the effect of the oxan-
drolone intervention on the parameters, while the
third shows its effect on the mean growth curve.
Results
The SITAR model
The SITAR model fitted the CHS data best on the
scales of height and log age. Table 1 shows the devi-
ances and residual standard deviations (RSDs) for the
alternative models in the CHS and TS datasets, con-
firming that for CHS log age provided a far better fit
than age (deviance 1460 units smaller), and height
was better than log height. Despite this, the effect
on the RSD was small. For the TS data, height and
age were slightly better than height and log age by
19 units of deviance.
In general, a shift on the log scale translates to a
scaling on the original scale. So a left–right shift on
the log age scale corresponds to a shrinking–
stretching on the age scale. Thus for the log age
model the age scale can be viewed as elastic and
fixed at zero, with the scale shrunk for early puberty
and stretched for later puberty.
Figure 2 shows the raw data for the CHS cohort, a
series of superimposed growth curves colour-coded to
identify individuals. The RSD about the fitted spline
curve is 6.6cm (data not shown). Figure 3 shows the
incremental effect of adjusting for each of the SITAR
parameters in turn, where each subject’s growth curve
Figure 1 Illustration of the SITAR model for height in
puberty. The solid line is the mean growth curve; the short
dashed lines indicate a vertical or height shift in the curve
corresponding to size (); the long dashed lines indicates a
horizontal or age shift corresponding to tempo () and the
dot-dashed lines represent a shrinking–stretching of the age
scale reflecting velocity ()
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and age scales. In Figure 3a, a random height offset
(i.e. the size parameter ) is adjusted for, so that in-
dividual curves are shifted up or down to minimize
the RSD, which is reduced to 2.3cm. In Figure 3b, a
random age offset is added (the tempo parameter ),
which shifts individual curves left–right and reduces
the RSD to 1.2cm. Finally, in Figure 3c the age scal-
ing is added (the velocity parameter ), which
shrinks–stretches individual curves and reduces the
RSD to 0.8cm. The three graphs show increasingly
obvious spiky outliers above and below the main
body of data, corresponding to height recording
errors at the time of measurement. To adjust for
this, Figure 3d trims residuals exceeding 2.4cm in
absolute value (n¼952 or 0.74%) so as to remove
the spikes but retain the main body of data. This re-
duces the RSD to 0.7cm.
Thus the estimation of, and adjustment for, the
SITAR parameters reduces the RSD from 6.6 to
0.7cm, a reduction in variance of 98.9%. The final
RSD is similar to the median RSD for PB curves
fitted to each individual.
4,5
Table 2 gives the standard deviations and correl-
ations of the growth parameter random effects for
the model in Figure 3c. Size is in units of cm,
tempo is fractional due to the log age scale and vel-
ocity is a fractional multiplier (the latter two can be
multiplied by 100 and viewed as percentages).
Multiplying tempo by mean APHV (14.3 years) con-
verts it to years, giving an SD of 0.97 years. The three
growth parameters correlate with each other at
around þ0.3, indicating that boys entering puberty
later (positive tempo ) tend to be taller (larger size
) and have a larger peak velocity ().
Figure 4 shows the individual raw and SITAR-
adjusted growth curves for the TS cohort, colour
coded by trial arm. The raw RSD is 5.9cm, which
shrinks to 0.6cm on adjustment for the three param-
eters. Thus again 99% of the variance is explained by
the SITAR model, and the remaining variability
matches that of the PB curve. On this basis it can
be argued that the three SITAR parameters explain
all the differences in growth between individuals, so
that they constitute a parsimonious summary of the
individual growth curves.
Table 3 summarizes the growth parameter random
effects for the model in Figure 4. Size is in units of cm
and tempo in years, while again velocity is fractional.
The tempo–velocity correlation of –0.46 differs
from the þ0.26 for the Christ’s Hospital data, and
shows that girls entering puberty early tend to have
the largest height velocity. (Endocrinological note—
most of the girls with TS did not enter puberty spon-
taneously, it was induced artificially, so tempo here
relates more to the later fall in velocity than the
earlier rise.)
Growth related to exposure and outcome
Table 4 relates the CHS pubertal height parameters to
the clinical outcomes 50 years later. It shows sum-
mary statistics and correlations with the three
SITAR parameters of age, height and IGF-1 as mea-
sured at mean age 63 years.
9 In addition, it gives
APHV as derived individually for each child.
9
Size and height are very strongly correlated
(r¼0.86), though tempo and velocity also correlate
with height to some extent. To clarify their relative
contributions, Table 5 shows the multiple regression
of later height on the three parameters, where the
standardized coefficients indicate the effect on
height of a 1-SD increase in each parameter. This
confirms that size is by far the strongest predictor
(þ5.5cm per SD), though both tempo and velocity
are also predictive in opposite directions ( 0.6 and
þ0.5cm per SD, respectively).
Table 4 also shows a strong correlation between
tempo and APHV (0.83). So tempo is closely related
Figure 2 CHS data—3245 height growth curves and
129508 heights from 9 to 19 years
Table 1 Comparison of SITAR models of height on age
with and without log transformation
Christ’s Hospital Turner Study
Model Deviance
Residual
(cm) Deviance
Residual
(cm)
Height vs log age 359450 0.786 3973.4 0.634
Height vs age 360910 0.791 3954.6 0.627
Log height vs log age 361150 0.792
a 4057.8 0.660
a
Log height vs age 362810 0.797
a 4039.8 0.653
a
Deviances and RSDs for the two cohorts under the four models,
ranked by size for CHS, with the minima shown in bold italic
font.
aRSD obtained by multiplying by the geometric mean of height.
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0.97cm for scaled tempo.
The next strongest correlations (0.20–0.22) are for
age with tempo, APHV and IGF-1. These represent
secular trends over the period of data collection
(1939–68), with puberty becoming earlier and IGF-1
higher. Finally there are smaller correlations of tempo
and APHV with IGF-1 ( 0.12 and  0.13, respectively,
P<0.0002). Thus the tempo of puberty (but not size
or velocity) is strongly correlated with IGF-1 50 years
later, and tempo and APHV are equally predictive.
As tempo and IGF-1 are both correlated with age,
the tempo vs IGF-1 association could be due to the
secular trend. Adjusting for age confirms this, the
correlation of IGF-1 with tempo or APHV falling
to  0.08 (P¼0.01, N¼1009).
Turning to the TS cohort, Figure 5 compares the
individual growth parameter values by trial arm.
There are small oxandrolone effects for size
[þ2.6cm, 95% confidence interval (CI) 0.4–4.7,
P¼0.02] and tempo ( 0.3 years, –0.7 to þ0.1,
P¼0.1), but velocity is dramatically larger in the
oxandrolone arm (þ23%, 16–30%, P¼10
–8).
Refitting the SITAR model with fixed parameter ef-
fects for differences between trial arms confirms this
pattern (results not shown). Figure 6 shows the sum-
mary spline curves, each with 4df, obtained for the
two trial arms separately, and they demonstrate the
steeper velocity in the oxandrolone arm. Analysis of
the final height data confirms that oxandrolone
increases final height by 4.5cm (1.9–7.2, P¼0.001)
(EJ Gault et al., submitted for publication).
Discussion
The findings show that Beath’s shape invariant model
is useful for analysing the pubertal height growth
curve, both in boys and girls. As well as providing
the mean growth curve, it summarizes the departure
Figure 3 The effect on Figure 2 of adjusting in turn for (a) size  (shifting curves vertically), (b) tempo  (shifting curves
horizontally), (c) velocity  (shrinking–stretching age scales), and (d) extreme outliers
Table 2 CHS data: summary statistics of SITAR pubertal
growth parameter random effects for 3245 subjects and
129508 measurements
SD Correlations
Size (cm) 6.1 Size Tempo
Tempo (fractional) 0.068 0.33
Velocity (fractional) 0.15 0.36 0.28
Residual (cm) 0.79
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three biologically meaningful parameters: size, tempo
and velocity. Furthermore, the model explains effect-
ively all the heterogeneity in growth between individ-
uals, as the residual variability about the fitted curves
is no greater than that obtained by fitting individual
PB curves.
4,5 The name SITAR is proposed for the
model as it superimposes by translation and rotation.
The SITAR model has some similarities with the
random intercept–random slope model, in that size
is a random intercept and velocity can be viewed as
a random slope. However, where the two differ is that
SITAR expects a nonlinear mean curve, and this
allows the tempo random effect to be estimated—if
the mean curve were linear the size and tempo effects
would be indistinguishable. Thus, the most innovative
aspect of SITAR is its random shift on the age scale.
The SITAR model should also be useful for endo-
crinologists in that it clarifies the nature of growth
in puberty. The substantial population heterogeneity
in pubertal height velocity shows itself as variability
in PHV and APHV. However, these two quantities are
effectively the same as the SITAR parameters velocity
and tempo, and the present analysis makes clear that
these parameters explain all the differences in growth
velocity in both the CHS and TS cohorts. Note that
the size parameter, which defines mean height and
hence is important to set the relative position of the
height distance curve, has no effect on the height
velocity curve. The SITAR parameterization shows
that differences in height velocity between individuals
are entirely explained by differences in their internal
‘growth body clock’.
The correlations between the three growth parameters
indicate that CHS boys entering puberty later tend to be
taller and have a larger peak velocity (Table 2). Girls
with TS show similar correlations except that tempo
and velocity are inversely related, with early puberty
associated with greater velocity (Table 3). This accords
with the fact that only a minority of girls with TS enter
puberty spontaneously—the others have puberty
induced artificially with oestrogen therapy, and their
growth spurt is much smaller.
The positive correlation between size and tempo ap-
pears to contradict the previously reported negative
correlation between height at school entry and
APHV.
9 Clearly, the correlations of the growth param-
eters with height at any particular age depend on the
values of the other parameters, as seen in Table 5 for
Figure 4 Turner Study data. Left: 105 height growth curves and 1321 heights from 9 to 19 years as randomized
(oxandrolone red solid lines, placebo blue dashed lines). Right: the same curves after SITAR adjustment
Table 3 Turner Study data: summary statistics of SITAR
pubertal growth parameter random effects for 105 subjects
and 1321 measurements
SD Correlations
Size (cm) 5.9 Size Tempo
Tempo (years) 1.04 0.29
Velocity (fractional) 0.23 0.28  0.46
Residual (cm) 0.63
SITAR—A USEFUL INSTRUMENT FOR GROWTH CURVE ANALYSIS 1563later height. Repeating this analysis for height at dif-
ferent ages in puberty shows that for size, a 1-SD
increase predicts an  6-cm increase in height at all
ages (which fits with the SD of  6cm for size in
Tables 2 and 3). For tempo, a 1-SD increase is asso-
ciated consistently with a reduction in predicted
height, peaking at –7cm at age 14. Thus around
APHV the tempo effect eclipses the size effect. For
velocity the effect is smaller, ranging from –2 to
þ1cm. So conditional on the other parameters,
tempo is consistently inversely associated with
height at any particular age, which accords with the
earlier finding.
9
The SITAR model is useful for relating individual
growth parameters to previous exposures and/or
later outcomes. The TS example shows how SITAR
provides a parsimonious analysis of the growth clin-
ical trial, where the oxandrolone intervention is not
only highly effective, but also is seen to operate pri-
marily by increasing growth velocity () rather than
tempo () or size (). The strength of the oxandro-
lone effect (P¼10
–8) is remarkable given the modest
number of growth curves involved (N¼105). Its
effect on the size parameter of þ2.6cm is less than
on final height (þ4.5cm) as it reflects mean height
throughout the study. In fact the Turner Study design
was more complex than described here, with two
separate randomizations in a factorial design, and
the net effect of oxandrolone on final height exceeded
7cm (EJ Gault et al., submitted for publication).
The CHS analysis relates the growth parameters to
IGF-1 50 years later, and again finds just one of the
three parameters to be important, this time tempo.
Hence, earlier puberty is associated with higher
IGF-1 after a lag of 50 years. The association is exag-
gerated by secular trends in tempo and IGF-1, but it
remains after adjusting for age.
APHV measured from individual growth curves
gives the same results as tempo. The high correlation
of 0.83 between the two suggests that they are mea-
suring essentially the same quantity, albeit on differ-
ent measurement scales. However, tempo is much
easier to estimate, being a random effect from a
single analysis, whereas APHV involves analysing
each individual growth curve.
Discussion of findings
The fact that the model fits well both in boys and
girls, even growth disordered girls with TS, highlights
its generality. The fit in the CHS boys was far better
with a log age scale, where a left–right shift on the
log age scale corresponds to a shrinking–stretching on
the age scale anchored at birth. This elasticity of the
growth curve affects the curve’s slope (i.e. velocity),
so that it is steeper for individuals with an early pu-
berty and shallower for those reaching puberty later
(see Figure 7 of Cole et al.
7). This provides a statistical
explanation for the clinical observation that PHV (vel-
ocity) is inversely correlated with APHV (tempo).
14
Thus log age provides a better fit for CHS because it
models this correlation. Indeed, it over-compensates,
as the negative correlation of  0.19 between tempo
and velocity on the age scale (result not shown)
switches to þ0.28 on the log age scale (Table 2).
The log age scale did not provide a better fit for the
girls with TS, which may be due to their mean vel-
ocity curve lacking a clear peak, due to most of them
failing to enter puberty spontaneously. Thus there was
less opportunity for an association between PHV and
APHV.
Strengths and weaknesses
The strengths of the study are the two substantial and
contrasting datasets that provide a useful test of the
generality of the SITAR approach. In addition, they
include examples of both exposure–growth and
growth–outcome associations, which highlight respect-
ively the velocity and tempo parameters of the model.
Table 4 CHS data: summary statistics and correlations of APHV and clinic measurements in later life
9 with SITAR pubertal
growth parameter random effects
Correlations
N Mean SD Size Tempo Velocity APHV Age Height
APHV (years) 1485 14.3 1.6 0.18 0.83 0.06 1
Age (years) 1028 63.3 6.7 –0.02 0.20 0.00 0.21 1
Height (cm) 1022 178.2 6.4 0.86 0.15 0.34 0.05 –0.15 1
IGF-1 (ng/ml) 1024 125 42 –0.02 –0.12 –0.03 –0.13 –0.22 0.03
Table 5 CHS data: multiple regression of height (cm) in
later life on SITAR random effects, adjusted for age of
measurement
Standardized
regression
coefficient
Standard
error t 95% CI
(Intercept) 178.2 0.10 1860 178.0 to 178.4
Size 5.5 0.10 53.1 5.3 to 5.7
Tempo –0.59 0.10 –5.7 –0.79 to –0.39
Velocity 0.54 0.10 5.3 0.34 to 0.74
Residual SD 3.0cm, R
2 ¼ 0.77.
1564 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYA weakness of the study is that the results apply
only to height in puberty. Their relevance to height
at other ages, e.g. pre-school, or to other
measurements, e.g. weight, is not known. That said,
Beath’s article describing the method
6 applied it to
weight from 0 to 2 years, where it appeared to fit
well, though the goodness of fit of the model was
not examined in the same way as here.
There is a need for future work to test the gener-
ality of the SITAR model, particularly in puberty
where the heterogeneity of height growth, which
appears to depend on the individual’s time clock,
may be related to the timing of changes in sex hor-
mone status. The SITAR approach would be useful to
examine hormone status in the same way as for
height.
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Figure 5 Turner Study. Comparison of the SITAR growth parameters by trial arm. Velocity is far greater for oxandrolone
(P¼10
–8)
Figure 6 Turner Study. The mean growth curves for the
two arms, indicating the greater velocity for oxandrolone
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  SITAR is a shape-invariant growth curve model that summarizes individual growth curves with a
single summary curve and subject-specific random effects.
  The random effects reflect each subject’s size, growth tempo and growth velocity.
  Two examples demonstrate that the model explains virtually all inter-individual variability in height
growth during puberty.
  This suggests that height growth variability arises from differences in subjects’ internal body clocks.
  The random effects are useful to relate growth to preceding exposures and later outcomes.
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